Ashley Kalinauskas, MS

Ashley Kalinauskas is the CEO of Torigen, a startup biotechnology company focused on providing personalized cancer immunotherapies to companion animals. Torigen is a team of veterinarians and researchers spun out of research from the University of Notre Dame focused on utilizing immunotherapy for cancer and immune-mediated diseases.